AptarGroup logo

AptarGroup dividend paid (ttm)NYSE: ATR

Dividend paid (TTM)

$11.11 B
+$295.00 M+2.73%

30 September 2024

new highvs 3 years high
+14.76%vs 3 years low
66.40%vs. sector
Performance
Most recent+2.7%
1 year+9.4%
3 years+14.8%
5 years+25.4%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend paid (TTM) performance

Most recent change
ATR+2.7%
TECH+0.1%
RDY-1.1%
RPRX+1.2%
1 year change
ATR+9.4%
TECH+0.1%
RDY-0.8%
RPRX+5.4%
3 years change
ATR+14.8%
TECH+1.4%
RDY+41.6%
RPRX+38.3%
5 years change
ATR+25.4%
TECH+4.1%
RDY+42.7%
RPRX-34.0%

Dividend paid (TTM) performance

ATRTECHGMEDSNNRDYRPRXCTLT
Most recent+2.7%+0.1%---1.1%+1.2%-
1 year+9.4%+0.1%---0.8%+5.4%-
3 years+14.8%+1.4%--+41.6%+38.3%-
5 years+25.4%+4.1%--+42.7%-34.0%-
FAQ

What is AptarGroup dividend paid (ttm)?

AptarGroup dividend paid (ttm) is $11.11 B

What is AptarGroup dividend paid (ttm) compared to its all-time maximum value?

AptarGroup dividend paid (ttm) is 100% of its all-time maximum value

What is AptarGroup dividend paid (ttm) compared to other companies from its sector (Healthcare)?

AptarGroup dividend paid (ttm) is higher than 66.4% of the companies in the same sector (Healthcare)

How has AptarGroup dividend paid (ttm) changed over the year?

Over the past year, AptarGroup dividend paid (ttm) has increased by 9.4%. During the same period, Bio-Techne has increased by 0.1%, Dr Reddys Laboratories Limited has dropped by 0.8%, Royalty Pharma has risen by 5.4%

How has AptarGroup dividend paid (ttm) changed over the 3 years?

During the last 3 years, AptarGroup dividend paid (ttm) has increased by 14.8%. Over the same period, Bio-Techne has increased by 1.4%, Dr Reddys Laboratories Limited has increased by 41.6%, Royalty Pharma has risen by 38.3%

How has AptarGroup dividend paid (ttm) changed over the 5 years?

For the past 5 years, AptarGroup dividend paid (ttm) has increased by 25.4%. In the same period, Bio-Techne has increased by 4.1%, Dr Reddys Laboratories Limited has increased by 42.7%, Royalty Pharma has decreased by 34.0%